Triggered release of pharmacophores from [Ni(HAsO3)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: A combined experimental and theoretical study

Sang Min Lee, One Sun Lee, Thomas V. O'Halloran, George C Schatz, SonBinh T. Nguyen

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Nanoscale drug delivery platforms can provide an attractive therapeutic strategy for cancer treatments, as they can substantially reduce the adverse side effects associated with toxic small-molecule anticancer agents. For enhanced therapeutic efficacy to be achieved with such platforms, a tumor-specific drug-release trigger is a critical requirement. This article reports the use of a pH-sensitive polymer network that surrounds a nanoscale liposome core to trigger the release of both encapsulated hydrophilic, membrane-impermeable NiII cations and amphipathic, membranepermeable As III anticancer agents under acidic conditions commonly encountered in hypoxic tumor tissues and late endosomes. Computational modeling studies provide clear evidence that the acidtriggered drug-release mechanism for this polymer-caged nanobin (PCN) platform arises from a pH-and temperature-responsive conformation change of the cross-linked polymer cage. As a result, the simultaneous release of both of the active agents in this multicomponent therapeutic enhances the pro-apoptotic activity of AsIII while diminishing its acute toxicity, potentially reducing the undesirable side effects commonly associated with this free drug. The ability to engender acidtriggered release of drugs co-encapsulated inside a liposomal template makes drug delivery using PCN an attractive strategy for triggered drug release.

Original languageEnglish
Pages (from-to)3961-3969
Number of pages9
JournalACS Nano
Volume5
Issue number5
DOIs
Publication statusPublished - May 24 2011

Fingerprint

Polymers
drugs
polymers
Drug delivery
Pharmaceutical Preparations
Tumors
Antineoplastic Agents
platforms
Oncology
Liposomes
delivery
Poisons
tumors
Toxicity
Conformations
actuators
Positive ions
Tissue
Cations
Membranes

Keywords

  • Arsenic trioxide
  • Drug delivery
  • Liposome
  • Molecular modeling
  • pH-sensitive release
  • Polymer

ASJC Scopus subject areas

  • Engineering(all)
  • Materials Science(all)
  • Physics and Astronomy(all)

Cite this

Triggered release of pharmacophores from [Ni(HAsO3)]-loaded polymer-caged nanobin enhances pro-apoptotic activity : A combined experimental and theoretical study. / Lee, Sang Min; Lee, One Sun; O'Halloran, Thomas V.; Schatz, George C; Nguyen, SonBinh T.

In: ACS Nano, Vol. 5, No. 5, 24.05.2011, p. 3961-3969.

Research output: Contribution to journalArticle

@article{25f093c7db9442548772e5e366cbd365,
title = "Triggered release of pharmacophores from [Ni(HAsO3)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: A combined experimental and theoretical study",
abstract = "Nanoscale drug delivery platforms can provide an attractive therapeutic strategy for cancer treatments, as they can substantially reduce the adverse side effects associated with toxic small-molecule anticancer agents. For enhanced therapeutic efficacy to be achieved with such platforms, a tumor-specific drug-release trigger is a critical requirement. This article reports the use of a pH-sensitive polymer network that surrounds a nanoscale liposome core to trigger the release of both encapsulated hydrophilic, membrane-impermeable NiII cations and amphipathic, membranepermeable As III anticancer agents under acidic conditions commonly encountered in hypoxic tumor tissues and late endosomes. Computational modeling studies provide clear evidence that the acidtriggered drug-release mechanism for this polymer-caged nanobin (PCN) platform arises from a pH-and temperature-responsive conformation change of the cross-linked polymer cage. As a result, the simultaneous release of both of the active agents in this multicomponent therapeutic enhances the pro-apoptotic activity of AsIII while diminishing its acute toxicity, potentially reducing the undesirable side effects commonly associated with this free drug. The ability to engender acidtriggered release of drugs co-encapsulated inside a liposomal template makes drug delivery using PCN an attractive strategy for triggered drug release.",
keywords = "Arsenic trioxide, Drug delivery, Liposome, Molecular modeling, pH-sensitive release, Polymer",
author = "Lee, {Sang Min} and Lee, {One Sun} and O'Halloran, {Thomas V.} and Schatz, {George C} and Nguyen, {SonBinh T.}",
year = "2011",
month = "5",
day = "24",
doi = "10.1021/nn200478m",
language = "English",
volume = "5",
pages = "3961--3969",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Triggered release of pharmacophores from [Ni(HAsO3)]-loaded polymer-caged nanobin enhances pro-apoptotic activity

T2 - A combined experimental and theoretical study

AU - Lee, Sang Min

AU - Lee, One Sun

AU - O'Halloran, Thomas V.

AU - Schatz, George C

AU - Nguyen, SonBinh T.

PY - 2011/5/24

Y1 - 2011/5/24

N2 - Nanoscale drug delivery platforms can provide an attractive therapeutic strategy for cancer treatments, as they can substantially reduce the adverse side effects associated with toxic small-molecule anticancer agents. For enhanced therapeutic efficacy to be achieved with such platforms, a tumor-specific drug-release trigger is a critical requirement. This article reports the use of a pH-sensitive polymer network that surrounds a nanoscale liposome core to trigger the release of both encapsulated hydrophilic, membrane-impermeable NiII cations and amphipathic, membranepermeable As III anticancer agents under acidic conditions commonly encountered in hypoxic tumor tissues and late endosomes. Computational modeling studies provide clear evidence that the acidtriggered drug-release mechanism for this polymer-caged nanobin (PCN) platform arises from a pH-and temperature-responsive conformation change of the cross-linked polymer cage. As a result, the simultaneous release of both of the active agents in this multicomponent therapeutic enhances the pro-apoptotic activity of AsIII while diminishing its acute toxicity, potentially reducing the undesirable side effects commonly associated with this free drug. The ability to engender acidtriggered release of drugs co-encapsulated inside a liposomal template makes drug delivery using PCN an attractive strategy for triggered drug release.

AB - Nanoscale drug delivery platforms can provide an attractive therapeutic strategy for cancer treatments, as they can substantially reduce the adverse side effects associated with toxic small-molecule anticancer agents. For enhanced therapeutic efficacy to be achieved with such platforms, a tumor-specific drug-release trigger is a critical requirement. This article reports the use of a pH-sensitive polymer network that surrounds a nanoscale liposome core to trigger the release of both encapsulated hydrophilic, membrane-impermeable NiII cations and amphipathic, membranepermeable As III anticancer agents under acidic conditions commonly encountered in hypoxic tumor tissues and late endosomes. Computational modeling studies provide clear evidence that the acidtriggered drug-release mechanism for this polymer-caged nanobin (PCN) platform arises from a pH-and temperature-responsive conformation change of the cross-linked polymer cage. As a result, the simultaneous release of both of the active agents in this multicomponent therapeutic enhances the pro-apoptotic activity of AsIII while diminishing its acute toxicity, potentially reducing the undesirable side effects commonly associated with this free drug. The ability to engender acidtriggered release of drugs co-encapsulated inside a liposomal template makes drug delivery using PCN an attractive strategy for triggered drug release.

KW - Arsenic trioxide

KW - Drug delivery

KW - Liposome

KW - Molecular modeling

KW - pH-sensitive release

KW - Polymer

UR - http://www.scopus.com/inward/record.url?scp=80051478841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051478841&partnerID=8YFLogxK

U2 - 10.1021/nn200478m

DO - 10.1021/nn200478m

M3 - Article

C2 - 21466214

AN - SCOPUS:80051478841

VL - 5

SP - 3961

EP - 3969

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 5

ER -